Replies to post #23852 on BioCurex, Inc.(fka BOCX)

[mcd2inga]

GS,
I have to say that, IMO, I do agree with other posters that you have gone from seeing all positives with BOCX to seeing all negatives. You do develop theories which you present as the only possible explanation. Lately, they always emphasize the nagative.
That's just how I see it.

I do agree that it seems strange why Dr. Moro would try to raise $6 million at this low share price. If Inverness makes the milestone payment, even if they don't say a word about progress and say nothing publicly, the share price of BOCX should go up. It will be a relief just to know Inverness is still working with Recaf towards a product. Placing shares should be much easier with a positive sign from Inverness. The boost in the share price could even save shareholders 50-100,000,000 shares of dilution. That would make a huge difference to the share price if/when BOCX has earnings per share.

Tell me if this is correct. The shares need to be authorized next week. The Inverness milestone payment is due or must be notified of intent in the November/December time frame. This could still happen before the new shares are placed. If this works out in BOCX's favor, BOCX could raise the funds needed at a higher share price and not place all of the authorized shares.
mcd

[opportunityknocking]

Goldseeker, do you honestly think you can create the illusion that Biocurex does not have a viable technology? You obviously can't convince the medical community which just keeps inviting Dr Moro back every year to the ISOBM. Did you try to call Dr Kramer? I didn't think so in case he might be in awe of what Biocurex has single-handedly accomplished. No false positives IMO IS the holy grail. He can still order the usual lab tests, but just add recaf to the list. This only confirms with 100% certainty his findings. It is a no brainer. We are not substituting any tests, we are only making the test better (perfect as a matter of fact) eliminating false positives. This was your original complaint. Being that you are not a doctor, and never treated a patient, or ordered a lab test, or prescribed medication, it is bewildering why you are so judgemental and seem to think you know what's best for modern medicine.

You have, and continue to try your best to create doubt which over time everyone here has drawn their own conclusions, so you know what they think, but now you are moving to other boards to prey on potential new investors. Tisk tisk. Just want you to know that you can attempt to change your alias, but now we know just how deliberate and desperate you have become.
You must be sensing the same thing we are all sensing. That we are about to emerge as a blockbuster biotech company with earnings and own a technology that will revolutionize medicine. The fact that you are focused soley on Biocurex and not AMDL or Panacea is very telling. There is no excuse for you to spend each day here and now we see what you do in between posts. JMHO
We are not a one trick pony. I expect multiple revenue streams. It's also a big world out there and anything breathing can benefit from recaf. Next week is a big week. The volume is nice to see. IMO something is in the works.
Prostate Cancer Stage Curability(b)
Stage I (or A) 87%
Stage II (or B) 81%
Stage III (or C) 64%
Stage IV (or D) 30%
Take your pick recaf or stage 3 or4